Scholarships are Available for the 2019 International Pain Summit Which Will be Held in LA this November

IPain The International Pain Foundation (IPain) is a nonprofit organization dedicated to supporting those with chronic pain due to neurological, musculoskeletal, inflammatory, degenerative, and emotional conditions. They aim to improve…

Continue Reading Scholarships are Available for the 2019 International Pain Summit Which Will be Held in LA this November

The First Ever PFIC Network Family Conference will Bring Families Affected by the Disease Together This Week

Emily Ventura has never met in-person another person living with progressive familial intrahepatic cholestasis (PFIC), her daughter’s life-threatening ultra-rare genetic disease. That will change on June 21st when Emily and…

Continue Reading The First Ever PFIC Network Family Conference will Bring Families Affected by the Disease Together This Week
Experimental Treatment for Hunter Syndrome Earns Rare Pediatric Disease Designation and Orphan Drug Designation
DarkoStojanovic / Pixabay

Experimental Treatment for Hunter Syndrome Earns Rare Pediatric Disease Designation and Orphan Drug Designation

According to a story from globenewswire.com, the biopharmaceutical company Denali Therapeutics, Inc. has recently announced that its experimental product candidate DNL310, which is currently being developed as a treatment for…

Continue Reading Experimental Treatment for Hunter Syndrome Earns Rare Pediatric Disease Designation and Orphan Drug Designation
Critical Research Into Amyotrophic Lateral Sclerosis Therapies Gets Funding Boost
TheDigitalWay / Pixabay

Critical Research Into Amyotrophic Lateral Sclerosis Therapies Gets Funding Boost

According to a story from Alabama News Center, a scientist affiliated with Southern Research, Dr. Rita Cowell, has been hard at work researching new potential treatments for amyotrophic lateral sclerosis,…

Continue Reading Critical Research Into Amyotrophic Lateral Sclerosis Therapies Gets Funding Boost

Presentations at the ATS Conference Demonstrate the Value of the Pulmonary Fibrosis Foundation’s Patient Registry

At the 2019 American Thoracic Society Conference this year multiple presentations demonstrated the importance of the Pulmonary Fibrosis Foundation's Patient Registry. About the Registry This registry was created by the Pulmonary…

Continue Reading Presentations at the ATS Conference Demonstrate the Value of the Pulmonary Fibrosis Foundation’s Patient Registry

Companies Announce Plan to Offer Free Genetic Tests for Patients With Suspected WHIM Syndrome or Severe Congenital Neutropenia

According to a story from Business Wire, the biopharmaceutical company X4 Pharmaceuticals, Inc. and the medical genetics company Invitae Corporation have recently announced that they have come into a parternship…

Continue Reading Companies Announce Plan to Offer Free Genetic Tests for Patients With Suspected WHIM Syndrome or Severe Congenital Neutropenia

Issues with Quality Assurance of Generic Drugs and How We Can Improve the Process

What are Generic Drugs? Generic drugs are any medications "equivalent" to brand name pharmaceuticals. These drugs are much cheaper than the brand name medications and the United States Food and…

Continue Reading Issues with Quality Assurance of Generic Drugs and How We Can Improve the Process

LEGO to Introduce Braille Bricks for Children who are Blind! Coming to Stores in 2020

The Importance of Braille For any child with a rare disease that leads to blindness or visual impairment such as Stargardt disease, Usher Syndrome, Alström syndrome, or Retinal Blindness life…

Continue Reading LEGO to Introduce Braille Bricks for Children who are Blind! Coming to Stores in 2020
Researchers Find Gut Bacteria that Can Change Type A Blood to Type O
source: pixabay.com

Researchers Find Gut Bacteria that Can Change Type A Blood to Type O

Blood Donations For many people living with a rare disease such as Beta thalassemia, Hemophilia, Aplastic Anemia, Myelodysplastic syndromes, Acute Promyelocytic leukemia, and others, blood transfusions are not uncommon. For…

Continue Reading Researchers Find Gut Bacteria that Can Change Type A Blood to Type O
12-Year-Old with Idiopathic Thrombocytopenic Purpura Creates Nonprofit to Make Transfusions Easier for Kids
source: pixabay.com

12-Year-Old with Idiopathic Thrombocytopenic Purpura Creates Nonprofit to Make Transfusions Easier for Kids

Ella Casano is a 12-year-old living with Idiopathic Thrombocytopenic Purpura (ITP) who had a brilliant idea about how she could help other children living with rare diseases like her own.…

Continue Reading 12-Year-Old with Idiopathic Thrombocytopenic Purpura Creates Nonprofit to Make Transfusions Easier for Kids
Research Highlights Distinctions Between Alzheimer’s Disease and Chronic Traumatic Encephalopathy
WikiImages / Pixabay

Research Highlights Distinctions Between Alzheimer’s Disease and Chronic Traumatic Encephalopathy

According to a story from news-medical.net, an international research team affiliated with the UK Medical Research Council, Indiana University School of Medicine, and the University of Kansas have released a…

Continue Reading Research Highlights Distinctions Between Alzheimer’s Disease and Chronic Traumatic Encephalopathy
Alnylam Pharmaceuticals Submits New Drug Application for Experimental Acute Hepatic Porphyria Drug
Aymanjed / Pixabay

Alnylam Pharmaceuticals Submits New Drug Application for Experimental Acute Hepatic Porphyria Drug

According to a press release from Alnylam Pharmaceuticals, the Massachusetts-based biopharmaceutical company has completed the submission of its New Drug Application (NDA) for givosiran — its experimental acute hepatic porphyria…

Continue Reading Alnylam Pharmaceuticals Submits New Drug Application for Experimental Acute Hepatic Porphyria Drug
First Patient Enrolled in Phase 3 Trial for Autosomal Dominant Polycystic Kidney Disease
Free-Photos / Pixabay

First Patient Enrolled in Phase 3 Trial for Autosomal Dominant Polycystic Kidney Disease

Do you have ADPKD? If you or someone you know has ADPKD, email us at [email protected]. We'd love to hear from you about your experience! According to a story from…

Continue Reading First Patient Enrolled in Phase 3 Trial for Autosomal Dominant Polycystic Kidney Disease

Phase 2 Clinical Trial for Microvillus Inclusion Disease Approved to Begin in Turkey

MVID Microvillus inclusion disease (MVID) is a rare, gastrointestinal disease which can cause impaired development in children. It is characterized by severe diarrhea which leads to dehydration and malnutrition. MVID…

Continue Reading Phase 2 Clinical Trial for Microvillus Inclusion Disease Approved to Begin in Turkey